Promega’s Maxwell RNA Extraction System has been authorized for use in the CDC’s COVID-19 diagnostic testing protocol, the company announced today.

The FDA granted the authorization on Monday.

“This announcement further validates why the Maxwell Extraction System is in such high demand by clinical testing labs seeking consistent and reliable benchtop automation,” Promega Director of Clinical Diagnostics Heather Tomlinson said in a statement. “We are happy our Maxwell customers that use the CDC’s protocol now have the flexibility of one more authorized RNA extraction option in the SARS-CoV-2 testing process.”

According to a release, the Maxwell RSC Instrument and Maxwell RSC Viral Total Nucleic Acid Purification Kit work together as an automated sample preparation solution that extracts RNA and DNA from viral samples.

In addition, the instrument and reagents have been incorporated into assay developers’ COVID-19 EUA assays.